AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26444863
Drug: Online monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Online monthly assessment + DEAL + 12-month access to a social networking site (Breathing Space)
Trial: 26444863
Drug: Online monthly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Online monthly self-assessments
Trial: 21390576
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine therapy for activating blood and dredging collaterals (ABDC)
Trial: 21390576
Drug: Western medical
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medical conventional treatment for anti‐inflammation and immunosuppression
Trial: 17230495
Drug: Psychotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy and relaxation in addition to standardized glucocorticoid therapy
Trial: 17230495
Drug: Standardized glucocorticoid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized glucocorticoid therapy (Control)
Trial: 11333065
Drug: Lithium 20
RxNorm normalized name: thenoate lithium 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium 20 mg/kg/day
Trial: 3946364
Drug: Mylanta II
RxNorm normalized name: Mylanta II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mylanta II 30 ml/h through a nasogastric tube to a maximum of 90 ml/h
Trial: 31979283
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of Eleutherococcus senticosus (ES) and Drynaria fortunei (DR) extracts for 12 weeks
Trial: 31979283
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of ES and DR extracts
Trial: 1458667
Drug: 0.125% amorolfine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.125% amorolfine cream
Trial: 1458667
Drug: 0.5% amorolfine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% amorolfine cream
Trial: 31112677
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen 60 minutes before surgery
Trial: 31112677
Drug: IV placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV placebo (100 mL of saline) before surgery
Trial: 31112677
Drug: IV placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV placebo (100 mL of saline) before and after surgery
Trial: 31112677
Drug: IV ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: IV ibuprofen 60 minutes after surgery
Trial: 30407151
Drug: Oral steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral steroids (20 mg for ages 2-5 years, 30 mg for ages 6-8 years)
Trial: 10376113
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg dehydroepiandrosterone
Trial: 10376113
Drug: 450 mg
RxNorm normalized name: aspirin 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg dehydroepiandrosterone
Trial: 2064115
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg prednisone daily (n = 8)
Trial: 2064115
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily (n = 8)
Trial: 25706340
Drug: Collaborative centralized
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collaborative centralized (CC) reminder/recall notifications
Trial: 25706340
Drug: Collaborative centralized
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collaborative centralized (CC) reminder/recall notifications endorsed by primary care practices
Trial: 19947568
Drug: Dexketoprofen trometamol
RxNorm normalized name: Dexketoprofen trometamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen trometamol (25 mg, tid) + terazosin (2 mg, qn)
Trial: 19947568
Drug: Indometacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indometacin (25 mg, tid) + terazosin (2 mg, qn)
Trial: 19947568
Drug: Terazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin (2 mg, qn)
Trial: 31479863
Drug: Alcohol (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (0.6 g/kg)
Trial: 11981385
Drug: Prednisone (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (80 mg/d for 4 d, then tapered over 8 d) with valacyclovir (1 g, 3 times a day for 10 days)
Trial: 2012351
Drug: No therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No therapy for patients older than 65 years
Trial: 7046318
Drug: Sclerosant injection
RxNorm normalized name: SCLEROSING AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerosant injection
Trial: 28905189
Drug: Bortezomib (1.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bortezomib (1.3 mg/m2) and Dexamethasone (20 mg)
Trial: 28905189
Drug: Bortezomib-Dexamethasone plus
RxNorm normalized name: Bortezomib
DrugBank: Bortezomib (DB00188)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Bortezomib-Dexamethasone plus Oral Cyclophosphamide (50 mg)
Trial: 26111665
Drug: McGRATH MAC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: McGRATH MAC laryngoscope (McG group)
Trial: 23749315
Drug: TENS (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS (30 min, twice a week for 12 weeks)
Trial: 23749315
Drug: TENS +
RxNorm normalized name: TEN
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS + Oxybutynin (multimodal treatment for 12 weeks)
Trial: 10091202
Drug: Oral 17
RxNorm normalized name: polyoxypropylene (17)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 17 beta‐estradiol, 2 mg/day for 3 months
Trial: 11247619
Drug: Selective serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective serotonin reuptake inhibitor (SSRI) medication
Trial: 29602978
Drug: Diane‐35 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane‐35 plus metformin (DM group)
Trial: 29602978
Drug: Diane‐35 plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane‐35 plus orlistat plus metformin (DOM group)
Trial: 27825638
Drug: Erlotinib (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erlotinib (150 mg)
Trial: 25138333
Drug: Sustained care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained care (n = 198) with automated interactive voice response telephone calls and choice of free smoking cessation medication for up to 90 days
Trial: 16328419
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy and exercise with physical therapy agents in both groups
Trial: 11219963
Drug: Triazolam (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triazolam (0.125 mg/70 kg)
Trial: 8637993
Drug: Oral CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral CT contrast agents
Trial: 20410089
Drug: n-3 long-chain
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 long-chain polyunsaturated fatty acid supplementation (200 mg EPA plus 500 mg DHA)
Trial: 16231596
Drug: Intensive Treatment
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive Treatment Group (n=6 students) received the basic module plus 'Student-related training in Contingency Management' (total 14h)
Trial: 16377322
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg intravenously
Trial: 24512
Drug: Diphenhydramine 50
RxNorm normalized name: diphenhydrAMINE 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine 50 mg orally
Trial: 24512
Drug: Diphenhydramine (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (both IV and oral)
Trial: 31770296
Drug: Pregabalin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (2 mg/kg twice daily for 5 days post-surgery)
Trial: 28112467
Drug: Percutaneous coronary
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES)
Trial: 15203432
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT) for six weekly one-hour sessions
Trial: 9935252
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trovafloxacin orally before surgery as a single dose
Trial: 9935252
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg trovafloxacin orally before surgery as multiple doses
Trial: 7860441
Drug: Therapeutic administration
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic administration of platelet concentrates
Trial: 7860441
Drug: Prophylactic administration
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic administration of platelets
Trial: 3354496
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of calcium absorption
Trial: 8324023
Drug: roxithromycin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: roxithromycin (300 mg daily for 10 days)
Trial: 8324023
Drug: amoxicillin-clavulanic
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: amoxicillin-clavulanic
Trial: 25018037
Drug: Abiraterone 1000
RxNorm normalized name: ABIRATERONE
DrugBank: Abiraterone (DB05812)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abiraterone 1000 mg plus prednisone 5 mg by mouth twice daily
Trial: 19120893
Drug: Tailored eradication
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tailored eradication therapy (PPI/AC for CAM-sensitive strains, PPI/AM for CAM-resistant strains)
Trial: 16634738
Drug: Anticoagulant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant therapy for 6 months
Trial: 16634738
Drug: Anticoagulant therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant therapy (6 weeks or 6 months)
Trial: 12711662
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment (2 weeks + 4 out-patient sessions)
Trial: 8923126
Drug: SSRIs (Fluoxetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRIs (Fluoxetine 20 mg once a day and Fluvoxamine 100 mg twice a day)
Trial: 1673110
Drug: Atenolol 50
RxNorm normalized name: atenolol 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol 50 mg (b.i.d.)
Trial: 1673110
Drug: Propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol 80 mg (b.i.d.)
Trial: 28423524
Drug: Weekly paclitaxel
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly paclitaxel (80 mg/m2 for 12 weeks)
Trial: 9344199
Drug: Combination clindamycin/benzoyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination clindamycin/benzoyl peroxide gel
Trial: 9344199
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide gel
Trial: 25172376
Drug: Twice-daily co-trimoxazole
RxNorm normalized name: clindamycin
DrugBank: Clindamycin (DB01190)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Twice-daily co-trimoxazole for 3 days
Trial: 25172376
Drug: Once-daily co-trimoxazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily co-trimoxazole for 5 days
Trial: 23740801
Drug: 1,000 mg
RxNorm normalized name: bran 1,000 mg ORAL WAFER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 mg ocrelizumab
Trial: 23740801
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ocrelizumab
Trial: 18805718
Drug: Immediate implants
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate implants augmented with autogenous bone graft
Trial: 16466172
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal treatment for clearing heat, detoxicating and nourishing Yin (CHM)
Trial: 9771244
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone
Trial: 8777828
Drug: Oral theophylline
RxNorm normalized name: theophylline Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral theophylline (10-20 mg/l blood levels)
Trial: 30114246
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of detemir (1.6 U/kg body weight)
Trial: 15719743
Drug: Zhibituo treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zhibituo treatment
Trial: 6228913
Drug: Aspirin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1 g/day)
Trial: 6401878
Drug: Aspirin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1 g/day) and Aspirin (1 g/day) + Dipyridamole (225 mg/day) combined
Trial: 348379
Drug: Diflunisal, 250
RxNorm normalized name: Diflunisal, 250 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflunisal, 250 mg twice daily
Trial: 17311843
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate/salmeterol combination treatment
Trial: 9719081
Drug: Low-dose intensity
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intensity
Trial: 9719081
Drug: Moderate-dose intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate-dose intensity
Trial: 9719081
Drug: High-dose intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intensity
Trial: 7715258
Drug: Continuous perfusion
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous perfusion of NTG at 2 mg/h (Group A)
Trial: 7715258
Drug: Continuous perfusion
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous perfusion of NTG at 4 mg/h (Group B)
Trial: 336057
Drug: Rheumon Gel
RxNorm normalized name: Rheumox
DrugBank: Etofenamate (DB08984)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rheumon Gel (etofenamate)
Trial: 144509
Drug: Ointment I
RxNorm normalized name: OINTMENT IN PACKET (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment I (2-hydroxyethyl salicylate and p-menthan-3-ol)
Trial: 144509
Drug: Ointment II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment II (3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidine)
Trial: 17761978
Drug: Thalidomide (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide (400 mg daily)
Trial: 24830937
Drug: MgCl2 5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgCl2 5% solution (30 mL, equivalent to 382 mg of magnesium)
Trial: 23710976
Drug: Methylphenidate or
RxNorm normalized name: methylphenidate Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate or dexamphetamine (titrated doses)
Trial: 22009030
Drug: Uninterrupted treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uninterrupted treatment (arm A)
Trial: 8976637
Drug: Testosterone propionate
RxNorm normalized name: Testosterone Propionate
DrugBank: Testosterone propionate (DB01420)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone propionate 50 mg intramuscularly every two weeks for one year
Trial: 25437223
Drug: Intravenous ferric
RxNorm normalized name: Ferric Oxide
DrugBank: Ferric oxide (DB11576)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous ferric carboxymaltose (500 mg)
Trial: 20436978
Drug: 15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg/kg acetaminophen orally
Trial: 11900816
Drug: Progesterone treatment
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone treatment (200 mg dose)
Trial: 10086963
Drug: No antiarrhythmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No antiarrhythmic therapy (Control)
Trial: 5389
Drug: 1.0 mg
RxNorm normalized name: HYDROCORTISONE BUTYRATE 1.0 mg in 1 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg fluoride - 42 mg sucrose tablets
Trial: 5389
Drug: Fluoride-free, sucrose-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride-free, sucrose-containing placebo tablets
Trial: 22706585
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of Clopidogrel and Rabeprazole
Trial: 19935143
Drug: Cardiac rehabilitation
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac rehabilitation with relaxation therapy (CPRT)
Trial: 1972487
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (75 mg daily)
Trial: 12215748
Drug: Low-dose sublingual
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose sublingual isosorbide dinitrate (2.5 mg) during HUTT
Trial: 12215748
Drug: Isoproterenol infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoproterenol infusion (1 to 3 µg/min) during HUTT
Trial: 9694469
Drug: Injection rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection rate of 2 ml/sec
Trial: 9694469
Drug: Injection rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection rate of 3 ml/sec
Trial: 9694469
Drug: Injection rate
RxNorm normalized name: tacrolimus
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Injection rate of 4 ml/sec
Trial: 11452241
Drug: Dapsone (daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone (daily and weekly dosing)
Trial: 30919036
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g myo-Inositol combined with 400 mg folic acid
Trial: 30919036
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg folic acid
Trial: 27098499
Drug: Oral sucrose
RxNorm normalized name: TootSweet 24% Oral Sucrose Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral sucrose (2 mL of 88% sucrose solution)
Trial: 27098499
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 mL of placebo solution)
Trial: 17641250
Drug: Transdermal GTN
RxNorm normalized name: GTN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal GTN 1.2 mg for 2 hours
Trial: 17641250
Drug: Pentaerythrityl tetranitrate
RxNorm normalized name: pentaerythrityl tetraethylhexanoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentaerythrityl tetranitrate (PETN) 80 mg
Trial: 30507875
Drug: Acetaminophen (200 mg/kg/d)
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (200 mg/kg/d)
Trial: 25415807
Drug: ZS‐9 (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS‐9 (2.5 g)
Trial: 25415807
Drug: ZS‐9 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS‐9 (5 g)
Trial: 25415807
Drug: ZS‐9 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS‐9 (10 g)
Trial: 25415807
Drug: ZS‐9 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS‐9 (5 g) during maintenance phase
Trial: 25415807
Drug: ZS‐9 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ZS‐9 (10 g) during maintenance phase
Trial: 10618526
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose for children with anti‐HBsAg concentrations below 10 mUI/ml
Trial: 10618526
Drug: Recombinant HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant HBV vaccine administered earlier
Trial: 21839625
Drug: Ciclesonide 80
RxNorm normalized name: CICLESONIDE 80MCG 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide 80 μg
Trial: 21839625
Drug: Ciclesonide 160
RxNorm normalized name: CICLESONIDE 160MCG 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide 160 μg
Trial: 26001339
Drug: Ciclesonide 80
RxNorm normalized name: CICLESONIDE 80MCG 60D ORAL INHL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciclesonide 80 μg and 160 μg
Trial: 25034652
Drug: Multidisciplinary pain
RxNorm normalized name: Dermoplast Pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary pain therapy for 4 weeks